Roche's Slow Growth Shouldn't Drive Investors Away

New treatments for various cancers, eye diseases, and more may bring in future revenues.

Related Keywords

Japan ,Germany ,Spain ,Italy ,Switzerland ,France ,Swiss ,Severin Schwan ,Roche Polivy ,Christoph Franz ,Actemra Roactemra ,Drug Administration ,View Research ,World Health Organization ,Emergen Research ,For Roche ,Emergency Use Authorization ,Grand View Research ,Coherent Market Insights ,Chairman Christoph Franz ,